Noteworthy ETF Flows: First Trust Nasdaq Pharmaceuticals ETF (FTXH) Rises 2.24% for Nov 16

November 16, 2016 - By Linda Rogers   ·   0 Comments

Nov 16 is a positive day so far for First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) as the ETF is active during the day after gaining 2.24% to hit $19.1 per share. The exchange traded fund has 1.94 million net assets and 0.20% volatility this month.

Over the course of the day 920 shares traded hands, as compared to an average volume of 350 over the last 30 days for First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH).

The ETF is -5.82% of its 52-Week High and 6.77% of its low, and is currently having ATR of 0.17. This year’s performance is -5.82% while this quarter’s performance is .

The ETF’s YTD performance is NaN%, the 1 year is NaN% and the 3 year is NaN%.

The ETF’s average P/E ratio is 21.53, the price to book is 2.31, the price to sales is 3.22 and the price to cashflow is 12.96. It was started on 9/22/2016. The fund’s top holdings are: Johnson & Johnson Common Stock for 8.85% of assets, Eli Lilly and Company Common St for 8.65%, Zoetis Inc. Class A Common Stoc for 8.52%, Merck & Company Inc. Common St for 8.52%, Abbott Laboratories Common Stoc for 8.50%, Prestige Brand Holdings Inc. C for 4.28%, Bristol-Myers Squibb Company Co for 4.04%, AbbVie Inc. Common Stock for 3.96%, Mylan N.V. for 3.92%, Lannett Co Inc Common Stock for 2.95%. The ETF sector weights are: Healthcare 100.00%. The ETF currently as yield.

More notable recent First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) news were published by: Etfdailynews.com which released: “First Trust Introduces Seven New Sector-Focused ETFs” on September 21, 2016, also Etftrends.com with their article: “7 First Trust Smart Sector ETFs to Diversify, Manage Risk” published on September 22, 2016, Benzinga.com published: “First Trust Gets Smart With New Sector ETFs” on September 26, 2016. More interesting news about First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) were released by: Nasdaq.com and their article: “Sage Therapeutics Becomes Oversold (SAGE)” published on November 03, 2016 as well as Nasdaq.com‘s news article titled: “ZTS Makes Notable Cross Below Critical Moving Average” with publication date: November 01, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Linda Rogers


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>